Richard Hague
2018 - Anika Therapeutics
In 2018, Richard Hague earned a total compensation of $827.2K as Chief Commercial Officer at Anika Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
Bonus | $105,779 |
---|---|
Option Awards | $363,305 |
Salary | $335,806 |
Other | $22,346 |
Total | $827,236 |
Hague received $363.3K in option awards, accounting for 44% of the total pay in 2018.
Hague also received $105.8K in bonus, $335.8K in salary and $22.3K in other compensation.
Rankings
In 2018, Richard Hague's compensation ranked 10,039th out of 14,244 executives tracked by ExecPay. In other words, Hague earned more than 29.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,039 out of 14,244 | 30th |
Division Manufacturing | 4,053 out of 5,765 | 30th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 539 out of 849 | 37th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 331 out of 547 | 40th |
Industry Surgical and Medical Instruments and Apparatus | 210 out of 348 | 40th |
Source: SEC filing on April 25, 2019.
Hague's colleagues
We found five more compensation records of executives who worked with Richard Hague at Anika Therapeutics in 2018.
2018
Charles Sherwood
Anika Therapeutics
Chief Executive Officer
2018
Joseph Darling
Anika Therapeutics
Chief Executive Officer
2018
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2018
Edward Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
2018
Thomas Finnerty
Anika Therapeutics